Assessing Health-Related Quality of Life and Willingness to Pay for Weight Management in Asia-Pacific by Gender

NCT06260696 | Completed

• 2 other identifiers: DAS-7626U1111-1282-5512
• Study Type: observational
• Target: 3,000
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of this survey is to collect information for scientific research and to identify the impact of overweight and obesity on health-related quality of life.

Conditions

Overweight; Obesity

Outcome Measures

Primary Outcomes (1)

• Score on IWQOL-Lite validated

  Calculated score. Likert scale; 1=Never True, 5=Always True

  At time of survey response (Day 1)

Study Arms (5)

Normal weight

Adults with normal weight, recruited to complete self-administered online service

Other: No treatment is given

Overweight

Adults with overweight, recruited to complete self-administered online service

Other: No treatment is given

Obesity Class I

Adults with obesity class I, recruited to complete self-administered online service

Other: No treatment is given

Obesity Class II

Adults with obesity class II, recruited to complete self-administered online service

Other: No treatment is given

Obesity Class III

Adults with obesity class III, recruited to complete self-administered online service

Other: No treatment is given

Interventions

No treatment is given OTHER

No treatment is given

Normal weight; Obesity Class I; Obesity Class II; Obesity Class III; Overweight

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Adults recruited to complete self-administered online service

You may qualify if:

• Informed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
• Male or female, age above or equal to 18 years at the time of signing informed consent.
• Not currently pregnant
• Does not participate in intense fitness or body building program
• Weight loss not through illness or injury
• Lives in South Korea, Australia, or India
• BMI above or equal to 18 and associated weight class (Normal Weight or above) will be determined by a programmed calculation based on participant-reported height and weight.

You may not qualify if:

• Previous participation in this study. Participation is defined as having given informed consent in this study
• Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation

Sponsors & Collaborators

• Novo Nordisk A/S: lead

Study Sites (1)

Novo Nordisk Investigational Site

Dubai, United Arab Emirates

Location

MeSH Terms

Conditions

Overweight; Obesity

Condition Hierarchy (Ancestors)

Overnutrition; Nutrition Disorders; Nutritional and Metabolic Diseases; Body Weight; Signs and Symptoms; Pathological Conditions, Signs and Symptoms

Study Officials

• Clinical Transparency (dept. 2834)

  Novo Nordisk A/S

  STUDY DIRECTOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: INDUSTRY
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: February 7, 2024
• First Posted: February 15, 2024
• Study Start: August 10, 2023
• Primary Completion: October 5, 2023
• Study Completion: October 5, 2023
• Last Updated: February 15, 2024

Record last verified: 2024-02

Data Sharing

• IPD Sharing: Will share

Locations

AE (1)